Ida Hiroshi

イダヒロシ | Ida Hiroshi

Homepage URL (1)： https://kaken.nii.ac.jp/d/r/90437294.ja.html

Research field (1)： Gastroenterology

Research keywords (8)： B型肝炎 , C型肝炎 , 肝細胞癌 , 膵液 , 胆汁 , 膵液・胆汁 , DNAメチル化 , RUNX3

Research theme for competitive and other funds (1)：

2009 - 2010 Development of detection of methylation of multiple tumor suppressor genes and its clinical application.

Papers (101)：

Tomoko Aoki, Masatoshi Kudo, Kazuomi Ueshima, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Yasunori Minami, Masakatsu Tsurusaki, et al. Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma. Liver cancer. 2024. 13. 1. 56-69
萩原智, 上嶋一臣, 西田直生志, 依田広, 三長孝輔, 南康範, 田北雅弘, 青木智子, 盛田真弘, 千品寛和, et al. Fontan術後に発症した切除不能肝細胞癌の1例. 肝臓. 2023. 64. 11. 567-574
萩原智, 上嶋一臣, 西田直生志, 依田広, 三長孝輔, 南康範, 田北雅弘, 青木智子, 盛田真弘, 千品寛和, et al. Fontan術後に発症した切除不能肝細胞癌の1例. 肝臓. 2023. 64. 11. 567-574
南康範, 松原卓也, 盛田真弘, 千品寛和, 青木智子, 田北雅弘, 萩原智, 依田広, 上嶋一臣, 西田直生志, et al. 肝細胞癌に対するアテゾリズマブ・ベバシズマブの初回投与直後に急速に発症し増悪した急性呼吸窮迫症候群の一剖検例. 肝臓. 2023. 64. Suppl.3. A873-A873
八田寛朗, 萩原智, 上嶋一臣, 大丸直哉, 松原卓哉, 盛田真弘, 千品寛和, 田北雅弘, 南康範, 依田広, et al. カボザンチニブ投与による腫瘍の著明な縮小、腫瘍マーカーの低下を認めたMET遺伝子増幅を伴う肝細胞癌の1例. 日本消化器病学会近畿支部例会プログラム・抄録集. 2023. 119回. 99-99

ｍore...

MISC (42)：

Masatoshi Kudo, Kazuomi Ueshima, Shin Nakahira, Naoshi Nishida, Hiroshi Ida, Yasunori Minami, Takuya Nakai, Hiroshi Wada, Shoji Kubo, Kazuyoshi Ohkawa, et al. Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 4
大丸直哉, 田北雅弘, 浦瀬篤史, 千品寛和, 青木智子, 萩原智, 依田広, 上嶋一臣, 鶴崎正勝, 鶴崎正勝, et al. リザーバー留置後に胃よりカテーテルの逸脱を認めた一例. リザーバー&ポート研究会プログラム・抄録集. 2022. 46th
Masatoshi Kudo, Kazuomi Ueshima, Shin Nakahira, Naoshi Nishida, Hiroshi Ida, Yasunori Minami, Takuya Nakai, Hiroshi Wada, Shoji Kubo, Kazuyoshi Ohkawa, et al. Adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 15
Masatoshi Kudo, Kazuomi Ueshima, Stephen Lam Chan, Tomoko Aoki, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Mamoru Takenaka, Tomohiro Watanabe, Masahiro Morita, et al. Initial lenvatinib therapy with no prior TACE in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
青木智子, 依田広, 盛田真弘, 南知宏, 田北雅弘, 萩原智, 南康範, 上嶋一臣, 西田直生志, 工藤正俊. Retrospective Cohort Study of CEUS evaluation of Lenvatinib for Disease Progression after PD-1/PD-L1/CTLA-4 Immune Checkpoint Inhibitor (ICI) in Advanced Hepatocellular Carcinoma. 超音波医学 Supplement. 2020. 47

ｍore...

Professional career (1)：

Medical degree (Kyoto University)

Work history (1)：

2009 - 2010 Kyoto University

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page